Prompt treatment of advanced-stage ovarian cancer by a gynecologic oncologist with a combination of surgery and chemotherapy is approved standard of care. Nonetheless, some patients are not evaluated by a gynecologic oncologist prior to starting their treatment.
Some patients are not evaluated by a gynecologic oncologist prior to starting their treatment.
In a recent study in the journal Gynecologic Oncology, researchers sought to review the treatment trends in patients treated for ovarian cancer and to evaluate the impact of care on survival. A total of 10,086 ovarian cancer patients who were treated between 2007 and 2018 were included. During the study period, there was an 8% increase in ovarian cancer patients undergoing assessment by a gynecologic oncologist and a 19% increase in surgeries performed by a gynecologic oncologist. Moreover, there was an increased risk for all-cause mortality in patients who were not assessed nor treated by a gynecologic oncologist before first treatment.
Increased risk for all-cause mortality in patients who were not assessed nor treated by a gynecologic oncologist before first treatment.
Consequently, assessment by a gynecologic oncologist before starting initial treatment is associated with improved survival in women diagnosed with advanced-stage ovarian cancer and should be considered standard of care.
More Ovarian Cancer Information:
About Women’s Cancer Research Foundation
The Women’s Cancer Research Foundation (WCRF) is one of the most active research organizations in the nation. We are dedicated to studying and evaluating novel treatments for women afflicted with breast, ovarian, endometrial, and cervical cancers. The WCRF persistently endeavors to make a difference in women’s lives by offering them hope, strength, and progress.
Laguna Beach, CA 92651
PH: (949) 642-5165
Follow Us On Social Media:
